A
Amicus Therapeutics
3 followers
Amicus Therapeutics, Inc. is a biotechnology company. The Company is engaged in the discovery, development and commercialization of a set of treatments for patients living with devastating rare and orphan diseases.
Org chart
Bradley L. Campbell
President & CEO
Bradley L. Campbell
Collapse
Jayne C. Gershkowitz
Chief Patient Advocate
Jeffrey P. Castelli
Chief Portfolio Officer and Head of Gene Therapy
Patrik Florencio
Senior Vice President, Global Chief Compliance & Risk Officer
Jill Weimer
Chief Science Officer
Pat Osullivan
Chief Technical Operations Officer
Sam Pierre-Louis
SVP Chief Information Officer
Jordan Masanoff
Senior Director, Business Development & Portfolio Planning
Heather Ramirez
Vice President, Legal
Megan Bilson
Sr. Vice President, Global HR & Talent Executive
Mike Keavany
President, US Business And Head, Global Marketing
Board & advisors
Burke W. Whitman
Director
Craig A. Wheeler
Director
Glenn P. Sblendorio
Director
Lynn D. Bleil
Director
Margaret G. Mcglynn
Director
Robert Essner
Director
Michael A. Kelly
Director
Eiry W. Roberts
Director
Michael G. Raab
Lead Independent Director